Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03112304 · ClinicalTrials.gov registry record · NA
Child STEPS for Youth Mental Health in Maine Sustainability
A NA study, sponsored by Harvard University.
- Completed
- Registry status
- NA
- Development phase
- 153
- Enrollment target
NCT03112304: Completed NA study, sponsored by Harvard University.
NCT03112304 is a NA study that has completed, run by Harvard University. The registered enrollment target is 153 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03112304, a NA study, has completed, sponsored by Harvard University.
- COMPLETED
- Registry status
- NA
- Development phase
- 153 participants
- Enrollment target
Study Summary
The overarching goal of this project is to study the sustainability of MATCH-ADTC within community mental health clinics, to learn what is needed for evidence-based practices (EBPs) to take root and thrive within a public system.
Interventions
- OTHER TRAC
- BEHAVIORAL MATCH-ADTC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2011-09 |
| Est. Completion | 2015-08 |
| Phase | NA |
What the finished NCT03112304 record still lists
NCT03112304 is an interventional study that assigns participants to a tested intervention. The registered 153 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which TRAC is the first listed.
NCT03112304 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03112304 about?
NCT03112304 is a clinical study titled "Child STEPS for Youth Mental Health in Maine Sustainability". The overarching goal of this project is to study the sustainability of MATCH-ADTC within community mental health clinics, to learn what is needed for evidence-based practices (EBPs) to take root and thrive within a public system.
What is the current status of trial NCT03112304?
This trial is currently completed. It is a NA study. The enrollment target is 153 participants. The study started on 2011-09. Estimated completion is 2015-08.
What interventions are being tested in trial NCT03112304?
The interventions under investigation include: TRAC (OTHER), MATCH-ADTC (BEHAVIORAL).
Who is sponsoring clinical trial NCT03112304?
This trial is sponsored by Harvard University, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03112304's enrollment target sits among peer trials
153 656th of 2000 higher than 1,343 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05283265 · 153 participants · NA
Neurophysiological Mechanisms of Language Comprehension
- NCT05554393 · 153 participants · Phase 2
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
- NCT05584501 · 153 participants · NA
ETE Interventions in the Dental Setting
- NCT05714839 · 153 participants · Phase 1
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia